SE8009102L - Estrar av l-arginin for anvendning vid behandling av akut lungodem, vissa chocktillstand och hyperfibrinolys - Google Patents

Estrar av l-arginin for anvendning vid behandling av akut lungodem, vissa chocktillstand och hyperfibrinolys

Info

Publication number
SE8009102L
SE8009102L SE8009102A SE8009102A SE8009102L SE 8009102 L SE8009102 L SE 8009102L SE 8009102 A SE8009102 A SE 8009102A SE 8009102 A SE8009102 A SE 8009102A SE 8009102 L SE8009102 L SE 8009102L
Authority
SE
Sweden
Prior art keywords
hyperfibrinolysis
esters
acute
lungodema
treatment
Prior art date
Application number
SE8009102A
Other languages
English (en)
Swedish (sv)
Inventor
G Sportoletti
A Baglioni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of SE8009102L publication Critical patent/SE8009102L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SE8009102A 1979-12-28 1980-12-23 Estrar av l-arginin for anvendning vid behandling av akut lungodem, vissa chocktillstand och hyperfibrinolys SE8009102L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28416/79A IT1127321B (it) 1979-12-28 1979-12-28 Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi

Publications (1)

Publication Number Publication Date
SE8009102L true SE8009102L (sv) 1981-06-29

Family

ID=11223557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8009102A SE8009102L (sv) 1979-12-28 1980-12-23 Estrar av l-arginin for anvendning vid behandling av akut lungodem, vissa chocktillstand och hyperfibrinolys

Country Status (24)

Country Link
US (2) US4308280A (xx)
JP (1) JPS56100717A (xx)
AR (1) AR227297A1 (xx)
AU (1) AU529650B2 (xx)
BE (1) BE886759A (xx)
BR (1) BR8008492A (xx)
CA (1) CA1166160A (xx)
DE (1) DE3027056A1 (xx)
DK (1) DK523980A (xx)
ES (1) ES497509A0 (xx)
FI (1) FI803995L (xx)
FR (1) FR2472387A1 (xx)
GB (1) GB2066073B (xx)
GR (1) GR72834B (xx)
IE (1) IE50550B1 (xx)
IN (1) IN151731B (xx)
IT (1) IT1127321B (xx)
LU (1) LU83028A1 (xx)
NL (1) NL8006706A (xx)
NO (1) NO803918L (xx)
PH (1) PH16250A (xx)
PT (1) PT72273B (xx)
SE (1) SE8009102L (xx)
ZA (1) ZA807514B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB897439A (en) * 1959-05-08 1962-05-30 American Cyanamid Co Compositions for intravenous use for blood clot lysis
JPS514125A (en) * 1974-06-27 1976-01-14 Mitsubishi Chem Ind N22 ashiru ll arugininesuterumatahasono sanfukaenno seizoho

Also Published As

Publication number Publication date
FR2472387B1 (xx) 1983-10-07
CA1166160A (en) 1984-04-24
GR72834B (xx) 1983-12-07
PT72273A (en) 1981-01-01
AU529650B2 (en) 1983-06-16
PH16250A (en) 1983-08-16
ZA807514B (en) 1981-11-25
IE50550B1 (en) 1986-05-14
NL8006706A (nl) 1981-07-16
IT1127321B (it) 1986-05-21
LU83028A1 (de) 1981-03-27
IN151731B (xx) 1983-07-16
FI803995L (fi) 1981-06-29
BR8008492A (pt) 1981-07-14
IT7928416A0 (it) 1979-12-28
US4405643A (en) 1983-09-20
GB2066073B (en) 1984-02-01
JPS56100717A (en) 1981-08-12
US4308280A (en) 1981-12-29
FR2472387A1 (fr) 1981-07-03
GB2066073A (en) 1981-07-08
AU6502880A (en) 1981-07-02
DK523980A (da) 1981-06-29
AR227297A1 (es) 1982-10-15
DE3027056A1 (de) 1981-07-02
JPS6342603B2 (xx) 1988-08-24
ES8205394A1 (es) 1982-06-16
IE802606L (en) 1981-06-28
PT72273B (en) 1981-11-05
BE886759A (nl) 1981-04-16
NO803918L (no) 1981-06-29
ES497509A0 (es) 1982-06-16

Similar Documents

Publication Publication Date Title
SE8009103L (sv) Farmaceutiska kompositioner innehallande en kortikosteroidsubstans
IT1207269B (it) Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
MX9308199A (es) Inhibidores de enzima.
DK0572942T4 (da) Orale farmaceutiske præparater til specifik frigivelse i kolon
RU92016445A (ru) Применение амидов изоксазол-4-карбоновой кислоты и амидов гидроксиалкилиденциануксусной кислоты
DE3170684D1 (en) An orally administered drug form comprising a polar bioactive agent and an adjuvant
EA200701913A1 (ru) Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
ES2148223T3 (es) Taxol encapsulado en liposomas y metodo para su uso.
NL930038I2 (nl) Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten.
ATE139439T1 (de) Pharmazeutische formulierung und pharmazeutisches verfahren
SE8009102L (sv) Estrar av l-arginin for anvendning vid behandling av akut lungodem, vissa chocktillstand och hyperfibrinolys
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
DE69421366T2 (de) Staurosporinderivate und Polyalkylenglykol-Glyceride enthaltende Arzneimittel
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
KR930702965A (ko) 생체이용성이 개선된 프로부콜 함유 제약 조성물
NL191368C (nl) Heterocyclisch gesubstitueerde biureetverbindingen en farmaceutische preparaten met pijnstillende werking.
JPS5791913A (en) Pharmaceutical preparation of drug
KR920702225A (ko) 약학 조성물
LU90791I2 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
AR004196A1 (es) Un metodo a alta velocidad para preparar granulos esfericos que comprende un medicamento para uso farmaceutico, granulos obtenibles mediante este metodoy una bolsita que contiene dichos granulos
FI842966A0 (fi) Triazolo-pyrimidinderivat, foerfarande foer deras framstaellning samt deras terapeutiska anvaendning som hjaertmediciner.
DE3884508T2 (de) Cystein-Derivate mit Expectorans-Wirkung.
MX9201482A (es) Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
ES2176258T3 (es) Uso de penciclovir en el tratamiento de la neuralgia post-herpeticas. a

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8009102-8